Gobi Partners

Gobi Partners is one of the older and more geographically distributed venture firms in Asia, with offices across Greater China, Southeast Asia, and the Middle East and a particular willingness to engage with research-heavy companies coming out of universities. The Kuala Lumpur hub sits at the center of its Southeast Asian healthcare and AI activity, while the broader platform draws on relationships with university ecosystems, including HKU, to source deep-tech opportunities.

The healthcare thesis covers AI/ML in healthcare, digital health, and biotech. Within that, Gobi tends to back companies applying machine learning to diagnostic and clinical workflow problems, digital health platforms targeting underserved Asian populations, and biotech teams whose underlying science was validated inside academic groups. The fund is comfortable with companies whose primary go-to-market is Asia first, including the more complex regulatory environments of mainland China, Hong Kong, and ASEAN markets, and it understands that the path to product-market fit looks different across those geographies.

Check sizes run from $1M to $5M across seed, Series A, and Series B. That range allows the fund to lead seeds in smaller markets and to participate meaningfully in Series A and B rounds led by larger firms. Founders should expect Gobi to be a useful partner specifically when they need help navigating cross-border expansion within Asia, including market entry support, regulatory introductions, and co-investor sourcing in adjacent geographies. The fund’s distributed structure means founders are typically matched with a partner closest to their primary market.

The team is large by Asian VC standards and includes investors with university research, operating, and policy backgrounds. Diligence reflects that mix, with attention paid to IP positions, regulatory pathways, and the credibility of management teams in markets where commercial outcomes can hinge on relationships as much as on product performance. Gobi is comfortable being patient with deep-tech companies whose timelines are measured in years rather than quarters.

For founders, the working relationship is shaped by Gobi’s pan-Asian footprint. Post-investment support tends to focus on follow-on syndication, market entry, regulatory navigation, and the practical mechanics of operating across multiple Asian countries. The fund is willing to engage with companies whose teams are split across geographies, which is increasingly common for healthcare and AI startups in the region. It is a less natural fit for companies whose primary market is the US or Europe and who want a lead investor focused on those geographies. It is a strong fit for technically credible teams whose ambitions span Asia and who want an investor who can actually help them operate across those markets rather than treat them as a single block. The fund’s tone with founders tends to be steady and patient rather than aggressive.